1. Home
  2. XGN
  3. XGN News

Latest Exagen Inc. (XGN) News on November 25, 2025

Why Analysts Are Updating Exagen’s Story After Higher Targets and Growth Outlook
XGN

Simply Wall St.

2 days ago

Why Analysts Are Updating Exagen’s Story After Higher Targets and Growth Outlook

Exagen Inc. to Participate in Fourth Quarter Investor Conferences
XGN

GlobeNewswire

14 days ago

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

How Analyst Views Are Shifting the Story for Exagen Amid New Growth Signals
XGN

Simply Wall St.

18 days ago

How Analyst Views Are Shifting the Story for Exagen Amid New Growth Signals

XGN

MT Newswires

20 days ago

B. Riley Adjusts Exagen Price Target to $18 From $15, Maintains Buy Rating

Exagen (XGN): Revenue Growth Outlook Challenges Bearish Sentiment as Valuation Remains Undemanding
XGN

Simply Wall St.

20 days ago

Exagen (XGN): Revenue Growth Outlook Challenges Bearish Sentiment as Valuation Remains Undemanding

Exagen Inc (XGN) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion ...
XGN

GuruFocus.com

20 days ago

Exagen Inc (XGN) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion ...

Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates
XGN

Zacks

21 days ago

Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates

Exagen Inc. Reports Strong Q3 2025 Results
XGN

GlobeNewswire

21 days ago

Exagen Inc. Reports Strong Q3 2025 Results

What To Expect From Exagen Inc (XGN) Q3 2025 Earnings
XGN

GuruFocus.com

22 days ago

What To Expect From Exagen Inc (XGN) Q3 2025 Earnings

Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
XGN

GlobeNewswire

a month ago

Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence

How the Narrative Around Exagen Is Shifting With Analyst Upgrades and Growth Signals
XGN

Simply Wall St.

a month ago

How the Narrative Around Exagen Is Shifting With Analyst Upgrades and Growth Signals

Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
XGN

GlobeNewswire

a month ago

Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025

Exagen Insider Ups Holding During Year
XGN

Simply Wall St.

5 months ago

Exagen Insider Ups Holding During Year

Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
XGN

GlobeNewswire

5 months ago

Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics

XGN

MT Newswires

5 months ago

Exagen Registers 1.15 Million Share Sale by Investor Perceptive Credit Holdings

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
XGN

GlobeNewswire

7 months ago

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares

Exagen First Quarter 2025 Earnings: Beats Expectations
XGN

Simply Wall St.

7 months ago

Exagen First Quarter 2025 Earnings: Beats Expectations

Exagen Inc. Prices Public Offering of Common Stock
XGN

GlobeNewswire

7 months ago

Exagen Inc. Prices Public Offering of Common Stock

Exagen Inc. Announces Proposed Public Offering of Common Stock
XGN

GlobeNewswire

7 months ago

Exagen Inc. Announces Proposed Public Offering of Common Stock

Exagen Inc (XGN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Wins Amidst ...
XGN

GuruFocus.com

7 months ago

Exagen Inc (XGN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Wins Amidst ...

XGN

Thomson Reuters StreetEvents

7 months ago

Q1 2025 Exagen Inc Earnings Call

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
XGN

Zacks

7 months ago

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates

Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume
XGN

GlobeNewswire

7 months ago

Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume

Exagen Inc (XGN) Q1 2025 Earnings Report Preview: What To Expect
XGN

GuruFocus.com

7 months ago

Exagen Inc (XGN) Q1 2025 Earnings Report Preview: What To Expect

Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors
XGN

GlobeNewswire

7 months ago

Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors

Institutional investors control 30% of Exagen Inc. (NASDAQ:XGN) and were rewarded last week after stock increased 30%
XGN

Simply Wall St.

7 months ago

Institutional investors control 30% of Exagen Inc. (NASDAQ:XGN) and were rewarded last week after stock increased 30%

Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025
XGN

GlobeNewswire

7 months ago

Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025

SurgePays And 2 Other Promising Penny Stocks To Watch
XGN

Simply Wall St.

8 months ago

SurgePays And 2 Other Promising Penny Stocks To Watch

Exagen Inc. (NASDAQ:XGN) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
XGN

Simply Wall St.

8 months ago

Exagen Inc. (NASDAQ:XGN) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Exagen Full Year 2024 Earnings: EPS Beats Expectations
XGN

Simply Wall St.

8 months ago

Exagen Full Year 2024 Earnings: EPS Beats Expectations

Exagen Inc (XGN) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives
XGN

GuruFocus.com

8 months ago

Exagen Inc (XGN) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives

XGN

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Exagen Inc Earnings Call

Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
XGN

Zacks

8 months ago

Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights
XGN

GlobeNewswire

8 months ago

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights

Investors in Exagen (NASDAQ:XGN) have unfortunately lost 84% over the last five years
XGN

Simply Wall St.

9 months ago

Investors in Exagen (NASDAQ:XGN) have unfortunately lost 84% over the last five years

Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025
XGN

GlobeNewswire

9 months ago

Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025

Strength Seen in Exagen (XGN): Can Its 29.4% Jump Turn into More Strength?
XGN

Zacks

10 months ago

Strength Seen in Exagen (XGN): Can Its 29.4% Jump Turn into More Strength?

Exagen Inc. to Participate in Upcoming Investor Conferences
XGN

GlobeNewswire

10 months ago

Exagen Inc. to Participate in Upcoming Investor Conferences

US Penny Stocks To Watch In January 2025
XGN

Simply Wall St.

10 months ago

US Penny Stocks To Watch In January 2025

Exagen Gains 28%, Insider Trades Reap Benefit
XGN

Simply Wall St.

10 months ago

Exagen Gains 28%, Insider Trades Reap Benefit

Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results
XGN

GlobeNewswire

10 months ago

Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
XGN

GlobeNewswire

a year ago

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD

Data Storage And 2 Other US Penny Stocks To Watch
XGN

Simply Wall St.

a year ago

Data Storage And 2 Other US Penny Stocks To Watch

Exagen Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
XGN

Simply Wall St.

a year ago

Exagen Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
XGN

GlobeNewswire

a year ago

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform

Exagen Inc. to Participate in Fourth Quarter Investor Conferences
XGN

GlobeNewswire

a year ago

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...
XGN

GuruFocus.com

a year ago

Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...

XGN

Thomson Reuters StreetEvents

a year ago

Q3 2024 Exagen Inc Earnings Call

Exagen Inc. (XGN) Reports Q3 Loss, Misses Revenue Estimates
XGN

Zacks

a year ago

Exagen Inc. (XGN) Reports Q3 Loss, Misses Revenue Estimates

November 2024 Penny Stocks On US Exchanges To Consider
XGN

Simply Wall St.

a year ago

November 2024 Penny Stocks On US Exchanges To Consider

Exagen Inc (XGN) Q3 2024 Earnings Report Preview: What To Expect
XGN

GuruFocus.com

a year ago

Exagen Inc (XGN) Q3 2024 Earnings Report Preview: What To Expect

Exagen to Announce Third Quarter 2024 Results on November 12, 2024
XGN

GlobeNewswire

a year ago

Exagen to Announce Third Quarter 2024 Results on November 12, 2024

Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
XGN

GlobeNewswire

a year ago

Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence

Shareholders in Exagen (NASDAQ:XGN) have lost 84%, as stock drops 12% this past week
XGN

Simply Wall St.

a year ago

Shareholders in Exagen (NASDAQ:XGN) have lost 84%, as stock drops 12% this past week

Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
XGN

GlobeNewswire

a year ago

Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference

Bears are Losing Control Over Exagen (XGN), Here's Why It's a 'Buy' Now
XGN

Zacks

a year ago

Bears are Losing Control Over Exagen (XGN), Here's Why It's a 'Buy' Now

Exagen (XGN) Shows Fast-paced Momentum But Is Still a Bargain Stock
XGN

Zacks

a year ago

Exagen (XGN) Shows Fast-paced Momentum But Is Still a Bargain Stock

Exagen Inc. (XGN) Soars to 52-Week High, Time to Cash Out?
XGN

Zacks

a year ago

Exagen Inc. (XGN) Soars to 52-Week High, Time to Cash Out?

Fast-paced Momentum Stock Exagen (XGN) Is Still Trading at a Bargain
XGN

Zacks

a year ago

Fast-paced Momentum Stock Exagen (XGN) Is Still Trading at a Bargain

Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates
XGN

Zacks

a year ago

Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates

Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
XGN

GlobeNewswire

a year ago

Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference

Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
XGN

GlobeNewswire

a year ago

Exagen Appoints Jeffrey G. Black as New Chief Financial Officer

Exagen to Announce Second Quarter 2024 Results on August 5, 2024
XGN

GlobeNewswire

a year ago

Exagen to Announce Second Quarter 2024 Results on August 5, 2024

Why Fast-paced Mover Exagen (XGN) Is a Great Choice for Value Investors
XGN

Zacks

a year ago

Why Fast-paced Mover Exagen (XGN) Is a Great Choice for Value Investors

XGN

GuruFocus.com

2 years ago

Exagen Inc (XGN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Margin ...

Exagen First Quarter 2024 Earnings: Beats Expectations
XGN

Simply Wall St.

2 years ago

Exagen First Quarter 2024 Earnings: Beats Expectations

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
XGN

Zacks

2 years ago

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates

Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
XGN

GlobeNewswire

2 years ago

Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year

Exagen Announces Campaign for Lupus Awareness Month
XGN

GlobeNewswire

2 years ago

Exagen Announces Campaign for Lupus Awareness Month

Exagen to Announce First Quarter 2024 Results on May 13, 2024
XGN

GlobeNewswire

2 years ago

Exagen to Announce First Quarter 2024 Results on May 13, 2024

Exagen Inc. Announces Changes to the Board of Directors
XGN

GlobeNewswire

2 years ago

Exagen Inc. Announces Changes to the Board of Directors

Analyst Estimates: Here's What Brokers Think Of Exagen Inc. (NASDAQ:XGN) After Its Annual Report
XGN

Simply Wall St.

2 years ago

Analyst Estimates: Here's What Brokers Think Of Exagen Inc. (NASDAQ:XGN) After Its Annual Report

Exagen Full Year 2023 Earnings: Beats Expectations
XGN

Simply Wall St.

2 years ago

Exagen Full Year 2023 Earnings: Beats Expectations

Exagen Inc. (NASDAQ:XGN) Q4 2023 Earnings Call Transcript
XGN

Insider Monkey

2 years ago

Exagen Inc. (NASDAQ:XGN) Q4 2023 Earnings Call Transcript

XGN

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Exagen Inc Earnings Call

Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
XGN

Zacks

2 years ago

Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
XGN

GlobeNewswire

2 years ago

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results

Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
XGN

GlobeNewswire

2 years ago

Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
XGN

GlobeNewswire

2 years ago

Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024

Despite Fast-paced Momentum, Exagen Inc. (XGN) Is Still a Bargain Stock
XGN

Zacks

2 years ago

Despite Fast-paced Momentum, Exagen Inc. (XGN) Is Still a Bargain Stock

Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
XGN

GlobeNewswire

2 years ago

Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

2 High-Yield Healthcare Stocks to Buy With Both Hands and 1 to Avoid for Now
XGN

Motley Fool

2 years ago

2 High-Yield Healthcare Stocks to Buy With Both Hands and 1 to Avoid for Now

XGN

GlobeNewswire

2 years ago

WiMi Developed An AI-driven Real-time Spatial Interaction Perception System for Interior Design

LeddarTech to Host Investor & Business Update Call on January 31, 2024
XGN

PR Newswire

2 years ago

LeddarTech to Host Investor & Business Update Call on January 31, 2024

Gain Therapeutics, Inc. (GANX) Upgraded to Strong Buy: Here's What You Should Know
XGN

Zacks

2 years ago

Gain Therapeutics, Inc. (GANX) Upgraded to Strong Buy: Here's What You Should Know

XGN

GlobeNewswire

2 years ago

WiMi Developed Interactive System Based on V-BCI Technology Incorporated into Holographic Glasses

Stewart Elected to Serve on the Head Office Board of Directors for the Federal Reserve Bank of San Francisco
XGN

GlobeNewswire

2 years ago

Stewart Elected to Serve on the Head Office Board of Directors for the Federal Reserve Bank of San Francisco

XGN

GlobeNewswire

2 years ago

WiMi Developed an LSTM-based Data Analysis System

XGN

GlobeNewswire

2 years ago

WiMi Developed a Trimmed K-Means Algorithm to Detect Crypto Wallet Fraud on the Bitcoin Network

The past five years for AmeriServ Financial (NASDAQ:ASRV) investors has not been profitable
XGN

Simply Wall St.

2 years ago

The past five years for AmeriServ Financial (NASDAQ:ASRV) investors has not been profitable

FingerMotion Inc (FNGR) Faces Revenue Decline in Q3 2024 Amid Market Challenges
XGN

GuruFocus.com

2 years ago

FingerMotion Inc (FNGR) Faces Revenue Decline in Q3 2024 Amid Market Challenges

XGN

GlobeNewswire

2 years ago

WiMi is Working on a New Mixed Byzantine Fault Tolerant (MBFT) Algorithm to Enhance Blockchain Fault Tolerance

5E Advanced Materials Announces Stockholder Approval of Proposed Out of Court Restructuring
XGN

GlobeNewswire

2 years ago

5E Advanced Materials Announces Stockholder Approval of Proposed Out of Court Restructuring

XGN

GlobeNewswire

2 years ago

WiMi is Working on the Blockchain Secure Storage Strategy Based on the MCMC Algorithm

XGN

GlobeNewswire

2 years ago

WiMi is Working on the Optimization of a Blockchain Hashing Algorithm Based on PRCA

XGN

GlobeNewswire

2 years ago

WiMi Developed PBO-Based Dynamic Optimization Algorithm That Can Be Applied to Blockchain and Bitcoin Trading Strategies

XGN

Business Wire

2 years ago

Solo Brands Announces Leadership Change to Support Its Next Chapter of Growth

Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
XGN

GlobeNewswire

2 years ago

Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance

Idaho Strategic Provides 2023 Year in Review
XGN

ACCESSWIRE

2 years ago

Idaho Strategic Provides 2023 Year in Review

Investors Sour on EV Charging Companies
XGN

The Wall Street Journal

2 years ago

Investors Sour on EV Charging Companies

Share on Social Networks: